Critical Care Management of Subarachnoid Hemorrhage and Ischemic Stroke

Clinics in Chest Medicine

Volumn 30, Issue 1, 2009, Pages 103-122

  Seder, David B ^a   Mayer, Stephan A ^b,c  

^a MAINE MEDICAL CENTER   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c Milstein Hospital   (United States)

Author keywords

Cerebral infarction; ICU management; Ischemic stroke; Medical complications; Multimodality monitoring; Subarachnoid hemorrhage

Indexed keywords

ACETYLSALICYLIC ACID; AMINOCAPROIC ACID; BENZODIAZEPINE DERIVATIVE; CONIVAPTAN; DOBUTAMINE; FOSPHENYTOIN SODIUM; HEPARIN; HYPERTENSIVE FACTOR; INSULIN; MANNITOL; NICARDIPINE; NORADRENALIN; PAPERAVINE; PHENYTOIN; PLACEBO; SODIUM CHLORIDE; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG; VASODILATOR AGENT; VERAPAMIL;

ADD ON THERAPY; ANALGESIA; ANEURYSM SURGERY; ANGIOPLASTY; ANTICOAGULANT THERAPY; ARTERIAL GAS; ARTERY CATHETERIZATION; ARTERY OCCLUSION; BASILAR ARTERY; BLOOD CLOT LYSIS; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BRAIN ANGIOGRAPHY; BRAIN ARTERY ANEURYSM; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN INJURY; BRAIN ISCHEMIA; CARDIOPULMONARY HEMODYNAMICS; CEREBROVASCULAR ACCIDENT; CHRONOTHERAPY; CLINICAL EVALUATION; CLINICAL TRIAL; CONTINUOUS INFUSION; CONVALESCENCE; DISEASE CLASSIFICATION; DISEASE SEVERITY; ELECTROENCEPHALOGRAPHY; EMBOLISM; FEEDING APPARATUS; FIBRINOLYSIS; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEMISPHERE; HUMAN; HYDROCEPHALUS; HYPERGLYCEMIA; HYPONATREMIA; HYPOTENSION; INTENSIVE CARE; INTRACRANIAL PRESSURE; INTRAVENOUS ADMINISTRATION; INTUBATION; LENGTH OF STAY; LOCKED IN SYNDROME; MAGNETIC RESONANCE ANGIOGRAPHY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN THERAPY; PATIENT MONITORING; PATIENT POSITIONING; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RECURRENT DISEASE; REHABILITATION MEDICINE; REPERFUSION; REVIEW; SEDATION; SEIZURE; SUBARACHNOID HEMORRHAGE; SURVIVAL; SURVIVOR; TRACHEOSTOMY; TREATMENT DURATION; VASOSPASM;

BRAIN ISCHEMIA; CRITICAL CARE; HUMANS; INTENSIVE CARE UNITS; MONITORING, PHYSIOLOGIC; SUBARACHNOID HEMORRHAGE;

EID: 58749097826     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2008.11.004     Document Type: Review

References (141)

1. Mocco J., Ransom E.R., Komotar R.J., et al. Preoperative prediction of long-term outcome in poor-grade aneurysmal subarachnoid hemorrhage. Neurosurgery 59 3 (2006) 529-538
2. Pereira A.R., Sanchez-Peña P., Biondi A., et al. Predictors of 1-year outcome after coiling for poor-grade subarachnoid aneurysmal hemorrhage. Neurocrit Care 7 1 (2007) 18-26
3. Weir R.U., Marcellus M.L., Do H.M., et al. Aneurysmal subarachnoid hemorrhage in patients with Hunt and Hess grade 4 or 5: treatment using the Guglielmi detachable coil system. AJNR Am J Neuroradiol 24 4 (2003) 585-590
4. Lindsberg P.J., Soinne L., Tatlisumak T., et al. Long-term outcome after intravenous thrombolysis of basilar artery occlusion. JAMA 292 15 (2004) 1862-1866
5. Lindsberg P.J., and Mattle. Therapy of basilar artery occlusion: a systematic analysis comparing intra-arterial and intravenous thrombolysis. Stroke 37 3 (2006) 922-928
6. Brandt T., von Kummer R., Müller-Kuppers M., et al. Thrombolytic therapy of acute basilar artery occlusion: variables affecting recanalization and outcome. Stroke 27 (1996) 875-881
7. Eckert B., Kucinski T., Pfeiffer G., et al. Endovascular therapy of acute vertebrobasilar occlusion: early treatment onset as the most important factor. Cerebrovasc Dis 14 (2002) 42-50
8. Wijdicks E., Nichols D.A., Thielen K.R., et al. Intra-arterial thrombolysis in acute basilar artery thromboembolism: the initial Mayo Clinic experience. Mayo Clin Proc 72 (1997) 1005-1013
9. Levy E.I., Firlik A.D., Wisniewski S., et al. Factors affecting survival rates for acute vertebrobasilar artery occlusions treated with intra-arterial thrombolytic therapy: a meta-analytical approach. Neurosurgery 45 (1999) 539-545
10. Gupta R., Connolly E.S., Mayer S., et al. Hemicraniectomy for massive middle cerebral artery territory infarction: a systematic review. Stroke 35 2 (2004) 539-543
11. Vahedi K., Hofmeijer J., Juettler E., et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol 6 3 (2007) 215-222
12. Laureys S., Pellas F., Van Eeckhout P., et al. The locked-in syndrome: what is it like to be conscious but paralyzed and voiceless?. Prog Brain Res 150 (2005) 495-511
13. Doble J.E., Haig A.J., Anderson C., et al. Impairment, activity, participation, life satisfaction, and survival in persons with locked-in syndrome for over a decade: follow-up on a previously reported cohort. J Head Trauma Rehabil 18 5 (2003) 435-444
14. Rosamond W., Flegal K., Furie K., et al. Heart disease and stroke statistics-2008 update: a report from the American Heart Association statistics committee and stroke statistics subcommittee. Circulation 117 (2008) e25
15. Hop J.W., Rinkel G.J., Algra A., et al. Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke 28 (1997) 660-664
16. Hacke W., Schwab S., Horn M., et al. Malignant middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol 53 4 (1996) 309-315
17. Aulmann C., Steudl W.I., and Feldmann. Validation of the prognostic accuracy of neurosurgical admission scales after rupture of cerebral aneurysms. Zentralbl Neurochir 59 3 (1998) 171-180
18. Juarez J.L., Tarr R.W., and Selman. Aneurysmal subarachnoid hemorrhage. N Engl J Med 354 4 (2006) 387-396
19. Claassen J., Bernardini G.L., Kreiter K., et al. Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher scale revisited. Stroke 32 (2001) 2012-2020
20. Coplin W.M., Pierson D.J., Cooley K.D., et al. Implications of extubation delay in brain-injured patients meeting standard weaning criteria. Am J Respir Crit Care Med 161 5 (2000) 1530-1536
21. Clancy M., Halford S., Walls R., et al. In patients with head injuries who undergo rapid sequence intubation using succinylcholine, does pretreatment with a competitive neuromuscular blocking agent improve outcome? A literature review. Emerg Med J 18 5 (2001) 373-375
22. Bilotta F., Branca G., Lam A., et al. Endotracheal lidocaine in preventing endotracheal suctioning-induced changes in cerebral hemodynamics in patients with severe head trauma. Neurocrit Care 8 2 (2008) 241-246
23. Duke B.J., Ryu R.K., Brega K.E., et al. Traumatic bilateral jugular vein thrombosis: case report and review of the literature. Neurosurgery 41 3 (1997) 680-683
24. Scheer B., Perel A., and Pfeiffer U.J. Clinical review: complications and risk factors of peripheral arterial catheters used for haemodynamic monitoring in anaesthesia and intensive care medicine. Crit Care 6 3 (2002) 199-204
25. Nieszkowska A., Combes A., Luyt C.E., et al. Impact of tracheostomy on sedative administration, sedation level, and comfort of mechanically ventilated intensive care unit patients. Crit Care Med 33 (2005) 2527-2533
26. Griffiths J., Barber V.S., Morgan L., et al. Systematic review and meta-analysis of the timing of tracheostomy in adult patients undergoing artificial ventilation. Br Med J 330 (2005) 1243
27. Rumbak M.J., Newton M., Truncale T., et al. A prospective, randomized study comparing early percutaneous dilational tracheostomy to prolonged translaryngeal intubation (delayed tracheostomy) in critically ill medical patients. Crit care Med 32 (2004) 1689-1694
28. Levine S., Nguyen T., Taylor N., et al. Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans. N Engl J Med 358 13 (2008) 1327-1335
29. Mayer S.A., Bernardini G.L., Solomon R.A., et al. Subarachnoid hemorrhage. In: Rowland L.P. (Ed). Merritt's textbook of neurology. 11th edition (2005), Lippincott, Williams, and Wilkins, Baltimore (MD) 328-338
30. Ransom E.R., Mocco J., Komotar R.J., et al. External ventricular drainage response in poor grade aneurysmal subarachnoid hemorrhage: effect on preoperative grading and prognosis. Neurocrit Care 6 3 (2007) 174-180
31. Komotar RJ, Schmidt JM, Starke RM, et al. Resuscitation and critical care of poor grade subarachnoid hemorrhage. Neurosurgery in press.
32. Adams Jr. H.P., and Gordon D.L. Nonaneurysmal subarachnoid hemorrhage. Ann Neurol 29 (1991) 461-462
33. Van Gijn J., and Rinkel G.J. Subarachnoid haemorrhage: diagnosis, causes and management. Brain 124 (2001) 249-278
34. Sehba F.A., and Bederson J.B. Mechanisms of acute brain injury after subarachnoid hemorrhage. Neurol Res 28 4 (2006) 381-398
35. Mocco J., Prickett C.S., Komotar R.J., et al. Potential mechanisms and clinical significance of global cerebral edema following aneurysmal subarachnoid hemorrhage. Neurosurg Focus 22 5 (2007) E7
36. Muroi C., Keller M., Pangalu A., et al. Neurogenic pulmonary edema in patients with subarachnoid hemorrhage. J Neurosurg Anesthesiol 20 3 (2008) 188-192
37. Mayer S.A., Lin J., Homma S., et al. Myocardial injury and left ventricular performance after subarachnoid hemorrhage. Stroke 30 4 (1999) 780-786
38. Lee V.H., Connolly H.M., Fulgham J.R., et al. Tako-tsubo cardiomyopathy in aneurysmal subarachnoid hemorrhage: an underappreciated ventricular dysfunction. J Neurosurg 105 2 (2006) 264-270
39. Naidech A.M., Kreiter K.T., Janjua N., et al. Cardiac troponin elevation, cardiovascular morbidity, and outcome after subarachnoid hemorrhage. Circulation 112 18 (2005) 2851-2856
40. Schmidt J.M., Rincon F., Fernandez A., et al. Cerebral infarction associated with acute subarachnoid hemorrhage. Neurocrit Care 7 1 (2007) 10-17
41. Sakowitz O.W., Raabe A., Vucak D., et al. Contemporary management of aneurysmal subarachnoid hemorrhage in Germany: results of a survey among 100 neurosurgical departments. Neurosurgery 58 1 (2006) 137-145
42. Starke R.M., Kim G.H., Fernandez A., et al. Impact of a protocol for acute antifibrinolytic therapy on aneurysm rebleeding after subarachnoid hemorrhage. Stroke (2008 Jul 24) EPub
43. Suarez J.I., Zaidat O.O., Suri M.F., et al. Length of stay and mortality in neurocritically ill patients: impact of a specialized neurocritical care team. Crit Care Med 32 (2004) 2311-2317
44. Bardach N.S., Olson S.J., Elkins J.S., et al. Regionalization of treatment for subarachnoid hemorrhage: a cost-utility analysis. Circulation 109 (2004) 2207-2212
45. Koenig M.A., Bryan M., Lewin III J.L., et al. Reversal of transtentorial herniation with hypertonic saline. Neurology 70 13 (2008) 1023-1029
46. Himmelseher S. Hypertonic saline solutions for treatment of intracranial hypertension. Curr Opin Anaesthesiol 20 5 (2007) 414-426
47. Suarez J.I., Qureshi A.I., Bhardwaj A., et al. Treatment of refractory intracranial hypertension with 23.4% saline. Crit Care Med 26 6 (1998) 1118-1122
48. van Gijn J., Hijdra A., Wijdicks E.F.M., et al. Acute hydrocephalus after aneurysmal subarachnoid hemorrhage. J Neurosurg 63 (1985) 355-362
49. Hasan D., Vermeulen M., Wijdicks E.F.M., et al. Management problems in acute hydrocephalus after subarachnoid hemorrhage. Stroke 20 (1989) 747-753
50. van Gign J., Kerr R.S., and Rinkel G.J.E. Subarachnoid hemorrhage. Lancet 369 (2007) 306-318
51. Ohkuma H., Tsurutani H., and Suzuki S. Incidence and significance of early aneurysmal rebleeding before neurosurgical or neurological management. Stroke 32 (2001) 1176-1180
52. Naidech A.M., Janjua N., Kreiter K.T., et al. Predictors and impact of aneurysm rebleeding after subarachnoid hemorrhage. Arch Neurol 62 3 (2005) 410-416
53. Broderick J.P., Brott T.G., Duldner J.E., et al. Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage. Stroke 25 (1994) 1342-1347
54. Komotar R.J., Zacharia B.E., Mocco J., et al. Controversies in the surgical treatment of ruptured intracranial aneurysms: the first annual J. Lawrence Pool memorial research symposium-controversies in the management of cerebral aneurysms. Neurosurgery 62 2 (2008) 396-407
55. Molyneux A.J., Kerr R.S., Yu L.M., et al. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet 366 (2005) 809-817
56. Solenski N.J., Haley Jr. E.C., Kassell N.F., et al. Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Crit Care Med 23 (1995) 1007-1017
57. Pasqualin A. Epidemiology and pathophysiology of cerebral vasospasm following subarachnoid hemorrhage. J Neurosurg Sci 42 Suppl 1 (1998) 15-21
58. Saqqur M., Zygun D., and Demchuk A. Role of transcranial Doppler in neurocritical care. Crit Care Med 35 Suppl 5 (2007) S216-S223
59. Chaudhary S.R., Ko N., Dillon W.P., et al. Prospective evaluation of multidetector-row CT angiography for the diagnosis of vasospasm following subarachnoid hemorrhage: a comparison with digital subtraction angiography. Cerebrovasc Dis 25 1-2 (2008) 144-150
60. Laslo A.M., Eastwood J.D., Pakkiri P., et al. CT perfusion-derived mean transit time predicts early mortality and delayed vasospasm after experimental subarachnoid hemorrhage. Am J Neuroradiol 29 1 (2008) 79-85
61. Rordorf G., Koroshetz W.J., Copen W.A., et al. Diffusion- and perfusion-weighted imaging in vasospasm after subarachnoid hemorrhage. Stroke 30 3 (1999) 599-605
62. Komotar R.J., Zacharia B.E., Otten M.L., et al. Controversies in the endovascular management of cerebral vasospasm after intracranial aneurysm rupture and future directions for therapeutic approaches. Neurosurgery 62 4 (2008) 897-905
63. Elliott J.P., Newell D.W., Lam D.J., et al. Comparison of balloon angioplasty and papaverine infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 88 (1998) 277-284
64. Zwienenberg-Lee M., Hartman J., Rudisill N., et al. Effect of prophylactic transluminal balloon angioplasty on cerebral vasospasm and outcome in patients with Fisher grade III subarachnoid hemorrhage: results of a phase II multicenter, randomized, clinical trial. Stroke 39 6 (2008) 1759-1765
65. Jestaedt L., Pham M., Bartsch A.J., et al. The impact of balloon angioplasty on the evolution of vasospasm-related infarction after aneurysmal subarachnoid hemorrhage. Neurosurgery 62 3 (2008) 610-617
66. Brisman J.L., Eskridge J.M., and Newell D.W. Neurointerventional treatment of vasospasm. Neurol Res 28 7 (2006) 769-776
67. Lylyk P., Vila J.F., and Miranda C. Partial aortic obstruction improves cerebral perfusion and clinical symptoms in patients with symptomatic vasospasm. Neurol Res 27 Suppl 1 (2005) S129-S135
68. Hänggi D., Beseoglu K., Turowski B., et al. Feasibility and safety of intrathecal nimodipine on posthaemorrhagic cerebral vasospasm refractory to medical and endovascular therapy. Clin Neurol Neurosurg (2008 Jun 11) Epub
69. Claassen J., Hirsch L.J., Kreiter K.T., et al. Quantitative continuous EEG for detecting delayed cerebral ischemia in patients with poor-grade subarachnoid hemorrhage. Clin Neurophysiol 115 12 (2004) 2699-2710
70. Claassen J., Mayer S.A., and Hirsch L.J. Continuous EEG monitoring in patients with subarachnoid hemorrhage. J Clin Neurophysiol 22 2 (2005) 92-98
71. Oddo M., and LeRoux P. Brain tissue oxygen monitors: more than an ischemia monitor. Crit Care Med 36 6 (2008) 1984-1985
72. Sarrafzadeh A.S., Sakowitz O.W., Kiening K.L., et al. Bedside microdialysis: a tool to monitor cerebral metabolism in subarachnoid hemorrhage patients?. Crit Care Med 30 5 (2002) 1062-1070
73. Rosenthal G., Hemphill III J.C., Sorani M., et al. Brain tissue oxygen tension is more indicative of oxygen diffusion than oxygen delivery and metabolism in patients with traumatic brain injury. Crit Care Med 36 (2008) 1917-1924
74. Steifel M.F., Spiotta A.M., Gracias V.H., et al. Reduced mortality in patients with severe traumatic brain injury in patients treated with brain tissue oxygen monitoring. J Neurosurg 103 (2005) 805-811
75. Frontera J.A., Fernandez A., Schmidt J.M., et al. Impact of nosocomial infectious complications after subarachnoid hemorrhage. Neurosurgery 62 1 (2008) 80-87
76. Naidech A.M., Jovanovic B., Wartenberg K.E., et al. Higher hemoglobin is associated with improved outcome after subarachnoid hemorrhage. Crit Care Med 35 10 (2007) 2383-2389
77. Wartenberg K.E., Schmidt J.M., Claassen J., et al. Impact of medical complications on outcome after subarachnoid hemorrhage. Crit Care Med 34 3 (2006) 617-623
78. Frontera J.A., Fernandez A., Claassen J., et al. Hyperglycemia after SAH: predictors, associated complications, and impact on outcome. Stroke 37 1 (2006) 199-203
79. Frontera J.A., Parra A., Shimbo D., et al. Cardiac arrhythmias after subarachnoid hemorrhage: risk factors and impact on outcome. Cerebrovasc Dis 26 1 (2008) 71-78
80. Fisher L.A., Ko N., Miss J., et al. Hypernatremia predicts adverse cardiovascular and neurological outcomes after SAH. Neurocrit Care 5 3 (2006) 180-185
81. Adams Jr. H.P., del Zoppo G., Alberts M.J., et al. Guidelines for the early management of adults with ischemic stroke. Circulation 115 20 (2007) e478-e534
82. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333 24 (1995) 1581-1587
83. Kent D.M., Ruthazer R., and Selker H.P. Are some patients likely to benefit from recombinant tissue-type plasminogen activator for acute ischemic stroke even beyond 3 hours from symptom onset?. Stroke 34 2 (2003) 464-467
84. Clark W.M., Wissman S., Albers G.W., et al. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. JAMA 282 21 (1999) 2019-2026
85. Hacke W., Kaste M., Bluhmki E., et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 358 (2008) 1317-1329
86. Chalela J.A., Kidwell C.S., Nentwich L.M., et al. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet 369 (2007) 293-298
87. Choi J.H., Bateman B.T., Mangla S., et al. Endovascular recanalization therapy in acute ischemic stroke. Stroke 37 (2006) 419-424
88. Janjua N., and Brisman J.L. Endovascular treatment of acute ischaemic stroke. Lancet Neurol 6 12 (2007) 1086-1093
89. Kidwell C.S., Chalela J.A., Saver J.L., et al. Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA 292 15 (2004) 1823-1830
90. Lee L.J., Kidwell C.S., Alger J., et al. Impact on stroke subtype diagnosis of early diffusion-weighted magnetic resonance imaging and magnetic resonance angiography. Stroke 31 5 (2000) 1081-1089
91. Katz D.A., Marks M.P., Napel S.A., et al. Circle of Willis: evaluation with spiral CT angiography, MR angiography, and conventional angiography. Radiology 195 2 (1995) 445-449
92. Tan J.C., Dillon W.P., Liu S., et al. Systematic comparison of perfusion-CT and CT-angiography in acute stroke patients. Ann Neurol 61 6 (2007) 533-543
93. Heidenreich J.O., Hsu D., Wang G., et al. Magnetic resonance imaging results can affect therapy decisions in hyperacute stroke care. Acta Radiol 49 5 (2008) 550-557
94. Sorensen A.G., Copen W.A., Ostergaard L., et al. Hyperacute stroke: simultaneous measurement of relative cerebral blood volume, relative cerebral blood flow, and mean tissue transit time. Radiology 210 2 (1999) 519-527
95. Fiebach J.B., Schellinger P.D., Gass A., et al. Stroke magnetic resonance imaging is accurate in hyperacute intracerebral hemorrhage: a multicenter study on the validity of stroke imaging. Stroke 35 2 (2004) 502-506
96. Neumann-Haefelin T., Wittsack H.J., Wenserski F., et al. Diffusion- and perfusion-weighted MRI. The DWI/PWI mismatch region in acute stroke. Stroke 30 8 (1999) 1591-1597
97. Furlan A., Higashida R., Wechsler L., et al. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study: a randomized controlled trial. JAMA 282 (1999) 2003-2011
98. Inoue T., Kimura K., Minematsu K., et al. Japan multicenter stroke investigator's collaboration. A case-control analysis of intra-arterial urokinase thrombolysis in acute cardioembolic stroke. Cerebrovasc Dis 19 (2005) 225-228
99. Macleod M.R., Davis S.M., Mitchell P.J., et al. Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovasc Dis 20 (2005) 12-17
100. Lewandowski C.A., Frankel M., Tomsick T.A., et al. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: emergency management of stroke (EMS) bridging trial. Stroke 30 (1999) 2598-2605
101. IMS Study Investigators. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke 35 (2004) 904-911
102. Han M.K., Kim S.H., Ko S.B., et al. Combined intravenous and intraarterial revascularization therapy using MRI perfusion/diffusion mismatch selection for acute ischemic stroke at 3-6 h after symptom onset. Neurocrit Care 8 (2008) 353-359
103. Gobin Y.P., Starkman S., Duckwiler G.R., et al. MERCI 1: a phase 1 study of mechanical embolus removal in cerebral ischemia. Stroke 35 (2004) 2848-2854
104. Sorimachi T., Fujii Y., Tsuchiya N., et al. Recanalization by mechanical embolus disruption during intra-arterial thrombolysis in the carotid territory. Am J Neuroradiol 25 (2004) 1391-1402
105. Smith W.S., Sung G., Saver J., et al. Mechanical thrombectomy for acute ischemic stroke: final results of the multi MERCI trial. Stroke 39 (2008) 1205-1212
106. Brekenfeld C., Schroth G., El-Koussy M., et al. Mechanical thromboembolectomy for acute ischemic stroke: comparison of the catch thrombectomy device and the merci retriever in vivo. Stroke 39 (2008) 1213-1219
107. Rordorf G., et al. Pharmacological elevation of blood pressure in acute stroke. Clinical effects and safety. Stroke 28 (1997) 2133-2138
108. Azzimondi G., Bassein L., Nonino F., et al. Fever in acute stroke worsens prognosis: a prospective study. Stroke 26 (1995) 2040-2043
109. Diringer M.N., Reaven N.L., Funk S.E., et al. Elevated body temperature independently contributes to increased length of stay in neurologic intensive care unit patients. Crit Care Med 32 (2004) 1489-1495
110. International Stroke Trial Collaborative Group. The International Stroke Trial (IST). A randomized trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischemic stroke. Lancet 349 (1997) 1569
111. Sandercock P., Gubitz G., Foley P., et al. Antiplatelet therapy for acute ischaemic stroke. Cochrane Database Syst Rev 2 (2003) CD000029
112. Albers G.W., Amarenco P., Easton J.D., et al. Antithrombotic and thrombolytic therapy for ischemic stroke: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126 Suppl 3 (2004) 483S-512S
113. Paciaroni M., Agnelli G., Micheli S., et al. Efficacy and safety of anticoagulant treatment in acute cardioembolic stroke. A meta-analysis of randomized controlled trials. Stroke 38 (2007) 423-430
114. Khatri P., Wechsler L.R., and Broderick J.P. Intracranial hemorrhage associated with revascularization therapies. Stroke 38 2 (2007) 431-440
115. Hamann G.F., del Zoppo G.J., and von Kummer R. Hemorrhagic transformation of cerebral infarction-possible mechanisms. Thromb Haemost 82 (1999) 92-94
116. Paciaroni M., Agnelli G., Corea F., et al. Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome: results of a prospective multicenter study. Stroke 39 (2008) 2249-2256
117. Alvarez-Sabin J., Molina C.A., Montaner J., et al. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator-treated patients. Stroke 34 5 (2003) 1235-1241
118. Ribo M., Molina C., Montaner J., et al. Acute hyperglycemia state is associated with lower tPA-induced recanalization rates in stroke patients. Stroke 36 8 (2005) 1705-1709
119. Alvarez-Sabin J., Molina C.A., Ribo M., et al. Impact of admission hyperglycemia on stroke outcome after thrombolysis: risk stratification in relation to time to reperfusion. Stroke 35 11 (2004) 2493-2498
120. Roine R.O., and Lindsberg P.J. Editorial comment-prime time for proactive blood glucose control?. Stroke 35 (2004) 2498-2499
121. Hacke W., Zeumer H., Ferbert A., et al. Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke 19 (1988) 1216-1222
122. Veltkamp R., Jacobi C., Kress B., et al. Prolonged low-dose intravenous thrombolysis in a stroke patient with distal basilar thrombus. Stroke 37 1 (2006) e9-e11
123. Grigoriadis S., Gomori J.M., Grigoriadis N., et al. Clinically successful late recanalization of basilar artery occlusion in childhood: what are the odds? Case report and review of the literature. J Neurol Sci 260 (2007) 256-260
124. Yu W., Kostanian V., and Fisher M. Endovascular recanalization of basilar artery occlusion 80 days after symptom onset. Stroke 38 (2007) 1387-1389
125. Cross III D.T., Moran C.J., Akins P.T., et al. Relationship between clot location and outcome after basilar artery thrombolysis. Am J Neuroradiol 18 (1997) 1221-1228
126. Lutsep H.L., Rymer M.M., and Nesbit G.M. Vertebrobasilar revascularization rates and outcomes in the MERCI and multi-MERCI trials. J Stroke Cerebrovasc Dis 17 (2008) 55-57
127. Albers G.W., Thijs V.N., Wechsler L., et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 60 (2006) 508-517
128. Alexandrov A.V., Hall C.E., Labiche L.A., et al. Ischemic stunning of the brain: early recanalization without immediate clinical improvement in acute ischemic stroke. Stroke 35 (2004) 449-452
129. Jaramillo A., Gongora-Rivera F., Labreuche J., et al. Predictors for malignant middle cerebral artery infarctions: a postmortem analysis. Neurology 66 (2006) 815-820
130. Agarwal P., Kumar S., Hariharan S., et al. Hyperdense middle cerebral artery sign: can it be used to select intra-arterial versus intravenous thrombolysis in acute ischemic stroke?. Cerebrovasc Dis 17 (2004) 182-190
131. Mattle H.P., Arnold M., Georgiadis D., et al. Comparison of intraarterial and intravenous thrombolysis for ischemic stroke with hyperdense middle cerebral artery sign. Stroke 39 (2008) 379-383
132. Von Kummer R., Meyding-Lamade U., Forsting M., et al. Sensitivity and prognostic value of early computed tomography in middle cerebral artery trunk occlusion. AJNR Am J Neuroradiol 15 (1994) 9-15
133. Krieger D.W., Demchuk A.M., Kasner S.E., et al. Early clinical and radiological predictors of fatal brain swelling in ischemic stroke. Stroke 30 (1999) 287-293
134. Kasner S.E., Demchuk A.M., Berrouschot J., et al. Predictors of fatal brain edema in massive hemispheric ischemic stroke. Stroke 32 (2001) 2117-2123
135. Wijman C.A. Editorial comment-can we predict massive space-occupying edema in large hemispheric infarctions?. Stroke 34 (2003) 1899-1900
136. Chen C.C., Cho D.Y., and Tsai S.C. Outcome of and prognostic factors for decompressive hemicraniectomy in malignant middle cerebral artery infarction. J Clin Neurosci 14 4 (2007) 317-321
137. Rabinstein A.A., Mueller-Kronast N., Maramattom B.V., et al. Factors predicting prognosis after decompressive hemicraniectomy for hemispheric infarction. Neurology 67 5 (2006) 891-893
138. Juttler E., Schwab S., Schmiedek P., et al. Decompressive surgery for the treatment of malignant infarction of the middle cerebral artery (DESTINY): a randomized, controlled trial. Stroke 38 (2007) 2518-2525
139. Hemicraniectomy after MCA infarction with life-threatening edema trial (HAMLET). Ongoing trial at the time of this review - details. Available at:. http://www.strokecenter.org/trials/trialDetail.aspx?tid=484 Accessed 12/23/2008
140. Carter B.S., Ogilvy C.S., Candia G.J., et al. One-year outcome after decompressive surgery for massive nondominant hemispheric infarction. Neurosurgery 40 (1997) 1168-1175
141. Kastrau F., Wolter M., Huber W., et al. Recovery from aphasia after hemicraniectomy for infarction of the speech-dominant hemisphere. Stroke 36 (2005) 825-829